angiotech

  1. T

    Angiotech Announces Long-Term Data Show Advantages For Taxus® Liberté® Stent In Smal

    Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, singlearm trials evaluating the TAXUS® Liberté®...
    • tD33NAt
    • Thread
    • advantages angiotech announces data libertãƒâ©â® longterm show smal stent taxusâ®
    • Replies: 0
    • Forum: Health and Fitness
  2. T

    Angiotech Pharmaceuticals And Partner Athersys Announce Updated Results From Phase I

    Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) ("Angiotech") and partner Athersys, Inc. (NASDAQ: ATHX) announced updated results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI)...
    • tD33NAt
    • Thread
    • angiotech announce athersys partner pharmaceuticals phase results updated
    • Replies: 0
    • Forum: Health and Fitness
  3. T

    Angiotech Announces That Cook Medical's Zilver® Ptx® Drug-Eluting Stent Meets Its Pri

    Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that a summary of the final clinical trial results for the randomized study of Cook Medical's Zilver® PTX® Drug-Eluting Peripheral Stent for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery...
    • tD33NAt
    • Thread
    • angiotech announces cook drugeluting medical meets pri ptxâ® stent zilverâ®
    • Replies: 0
    • Forum: Health and Fitness
Back
Top